Greenwich LifeSciences, Inc. (GLSI) vs Nautilus Biotechnolgy, Inc. (NAUT)
A side-by-side comparison of Greenwich LifeSciences, Inc. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GLSI
Greenwich LifeSciences, Inc.
$16.54HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
NAUT
Nautilus Biotechnolgy, Inc.
$1.90HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — GLSI vs NAUT
growth of $100 · dividends reinvested · last 6yGLSI +238.2% (+22.5%/yr)NAUT -82.5% (-25.2%/yr)GLSI compounded faster over this window
Log scale — wide-divergence pair
GLSI NAUT
GLSI vs NAUT: by the numbers
- •GLSI is the larger company ($243M vs $242M market cap).
- •Both run net losses; GLSI's is the smaller (0.00% vs -29747.89% net margin).
Metrics side by side
Valuation
| Metric | GLSI | NAUT |
|---|---|---|
| P/S ratio | N/A | 1272.55 |
| P/B ratio | 77.89 | 1.84 |
Profitability
| Metric | GLSI | NAUT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -29747.89% |
| ROE | -695.56% | -43.11% |
| ROIC | -701.55% | -40.52% |
Growth (annualized)
| Metric | GLSI | NAUT |
|---|---|---|
| Total return CAGR (5Y) | -14.84% | -20.56% |
Frequently asked
- How have GLSI and NAUT total returns compared?
- Over the past 5 years, GLSI delivered -14.84% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.